Curaleaf asks Alberta regulator to halt Aurora ATM share sales during US$4 offer
Dilution and cost impact cited in filing
Aurora has issued about 2,810,000 shares at an average US$3.04 since June 2026, lifting the offer cost by over US$11 million.
Curaleaf estimates dilution at about 4.9% since June 2026, rising to about 10.8% since the ATM program began in February 2026.
Curaleaf seeks pause on Aurora share issuance
Curaleaf’s outstanding offer seeks to acquire all of Aurora’s issued and outstanding shares at US$4 per share.
Curaleaf asked the Alberta Securities Commission to halt Aurora’s at-the-market share issuance program while the offer remains open.
The filing argues the ATM program dilutes shareholders, raises the offer’s total cost, and complicates meeting tender thresholds.
